Moxifloxacin Ophthalmic Solution
Sponsors
National University of Malaysia, Indonesia University
Conditions
CataractEndophthalmitisEndophthalmitis Postoperative
Phase 1
The Clinical Safety of Levofloxacin 1.5% vs Topical Moxifloxacin 0.5%
NCT04212429
Start: 2019-09-23End: 2022-05-31Target: 128Updated: 2020-10-14
The Pharmacokinetics of Topical Levofloxacin 1.5% vs Topical Moxifloxacin 0.5%
NCT04214821
Start: 2019-09-23End: 2022-05-31Target: 128Updated: 2020-10-14
Safety Profile Comparison of Undiluted Intracameral Moxifloxacin vs. Levofloxacin in Cataract Surgery
CompletedNCT05741632
Start: 2023-02-01End: 2023-04-01Updated: 2023-08-22